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SUMMARY. The present study was undertaken to evaluate the comparative antidepressant activity of Oci-
mum sanctum (OS) and imipramine using animal models of depression. Imipramine (15 mg/kg/i.p) and
herbal extract of OS (500 mg/kg/p.o) were subjected for its antidepressant activity using four different ani-
mal models of depression, viz: Forced Swimming Test (FST), Reserpine Reversal Test (RRT), Haloperi-
dol-Induced Catalepsy (HIC), and Pentobarbitone Sleeping Time (PST) in male Wistar rats. The study af-
ter single administration of OS and imipramine revealed a statistically significant reduction in immobility
time in FST, RRT, and protection against HIC, compared to control respectively. However there was no
significant potentiation of PST. The antidepressant activity of OS was comparable to that of standard
drug imipramine. The results of the present study indicate the potential for use of OS as an adjuvant in
the treatment of depression.
